Home ProductsWeight Losing Raw Materials

99.18% USP37 Pharmaceutical Raw Materials Weight Loss Oxedrine Weight Loss Anabolic Steroids

I'm Online Chat Now

99.18% USP37 Pharmaceutical Raw Materials Weight Loss Oxedrine Weight Loss Anabolic Steroids

99.18% USP37 Pharmaceutical Raw Materials Weight Loss Oxedrine Weight Loss Anabolic Steroids
99.18% USP37 Pharmaceutical Raw Materials Weight Loss Oxedrine Weight Loss Anabolic Steroids 99.18% USP37 Pharmaceutical Raw Materials Weight Loss Oxedrine Weight Loss Anabolic Steroids 99.18% USP37 Pharmaceutical Raw Materials Weight Loss Oxedrine Weight Loss Anabolic Steroids

Large Image :  99.18% USP37 Pharmaceutical Raw Materials Weight Loss Oxedrine Weight Loss Anabolic Steroids

Product Details:
Place of Origin: China
Brand Name: YUECUI
Certification: ISO9001
Model Number: 96829-58-2
Payment & Shipping Terms:
Minimum Order Quantity: 10G
Price: USD 1USD/G
Packaging Details: Standard Fast Delievery
Delivery Time: 5-8 days
Payment Terms: T/T, Western Union
Supply Ability: 5000g/Month

99.18% USP37 Pharmaceutical Raw Materials Weight Loss Oxedrine Weight Loss Anabolic Steroids

Description
Product Name: Orlistat MF: C29H53NO5
Storage Temp: 2-8°C Solubility DMSO: 19 Mg/mL
Appearance: White Crystalline Powder Packaging Details: Stealth And Discreet Packaging

99.18% USP37 Pharmaceutical Raw Materials Weight Loss Oxedrine Weight Loss Anabolic Steroids

 

 

The recommended starting dose is 10 mg once a day, either alone in the morning or with food. If weight loss is insufficient, the dose can be adjusted to 15 mg per day after 4 weeks. If the patient cannot tolerate the 10 mg dose, it can be reduced to 5 mg. The dose should be adjusted according to the patient's blood pressure and heart rate. Doses above 15 mg / day are not recommended.

 

Description:

Orlistat (also known as tetrahydrolipstatin) is a drug designed to treat obesity.Its primary function

 

is preventing the absorption of fats from the human diet by acting as a lipase inhibitor, thereby

 

reducing caloric intake. It is intended for use in conjunction with a healthcare provider-supervised

 

reduced-calorie diet.

 

 

Usage:

1. Orlistat is used for the treatment of obesity. The amount of weight loss achieved with orlistat

 

varies. In one-year clinical trials, between 35.5% and 54.8% of subjects achieved a 5% or greater

 

decrease in body mass, although not all of this mass was necessarily fat. Between 16.4% and

 

24.8% achieved at least a 10% decrease in body fat. After orlistat was stopped, a significant

 

number of subjects regained weight-up to 35% of the weight they had lost.

 

 

2. The incidence of type 2 diabetes in an obese population over four years is decreased with

 

orlistat (6.2%) compared to placebo (9.0%). Long-term use of orlistat also leads to a modest

 

reduction in blood pressure (mean reductions of 2.5 and 1.9 mmHg in systolic and diastolic blood

 

pressure respectively).

 

 

Benefits:

Studies have shown that, on average, orlistat, plus a weight-reducing diet and exercise, causes

 

more weight loss than a weight-reducing diet and exercise alone. Some people lose 10% or

 

more of their body weight within six months with the help of orlistat. In others, it is less effective.

 

One reason why orlistat may not work is that you may think that you can relax your weight-

 

reducing diet, and the orlistat will 'do it all'. This is not true. In order to lose weight you still have to

 

eat less, and exercise regularly. Remember, orlistat prevents only some of the fat that you eat

 

from being absorbed (just under a third). But, if you do not keep to a healthy weight-reducing diet,

 

and you eat more fat (chocolates, cakes, etc), the extra fat that you eat will easily cancel out the

 

effect of the orlistat.

 


What is the usual length of treatment ?

If you have lost 5% of your weight within three months, there is no restriction on how long orlistat

 

may be prescribed. However, most doctors will review treatment regularly, and will decide if it is

 

still appropriate for you to carry on taking orlistat. If you continue to lose weight after six months,

 

your doctor may advise that you continue to take orlistat. This may be for up to 1-2 years, or

 

longer if you have a great deal of weight to lose.

 

 

Product Name L-Carnitine Tartrate 541-15-1
Items Tested Specification Result
Purity
L-carnitine 68.2%±1.0% 68.34%
L-Tartrate acid 31.8%±1.0 31.56
Description White crystalline powder White crystalline powder
Identification IR & UV Confirm
Specific rotation -9.5°~-11.0° -10.21°
PH 3.0~4.5 3.71
Loss on drying ≤0.5% 0.07%
Residue on ignition(sulfated) ≤0.2% 0.05%
Total Heavy metals ≤10ppm 5ppm
Pb ≤2ppm 0.9ppm
Hg ≤0.1ppm 0.08ppm
As ≤1ppm 0.8ppm
Cd ≤1ppm 0.1ppm
Microbiology Control
Total Plate Count <1,000cfu/g 80cfu/g
Total Yeast & Mold <100cfu/g 20cfu/g
Staphylococcus Negative /1g Negative
E.Coli. Negative/1g Negative
Salmonella Negative /10g Negative

 

Most Powerful Weight Loss Drugs Powder CAS 52009-14-0 Calcium Pyruvate 0

 

L Carnitine Fat Loss Injections Steroids For Losing Weight CAS 541-15-1 1

Contact Details
Zhejiang Yuecui Trading Co., Ltd

Contact Person: 张国庆

Tel: +861314804998

Send your inquiry directly to us (0 / 3000)